Notably, our study revealed that CD8+ T cells of the mice immunized with the MC38 CRC cells plus rGRA6Nt adjuvant secrete approximately 40-times greater amounts of IFN-γ in response to MC38 tumor cells than the T cells of the unimmunized control mice do, as shown in Figure 4. This evidence concerns the gene CD8A and neoplasm.